Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a booklet help kidney patients stick to their meds?

NCT ID NCT07430449

Symptom relief Sponsor: Trakya University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at whether a training booklet based on Roy's Adaptation Model could help kidney patients who are starting immunosuppressive therapy. The booklet covers topics like what the drugs do, side effects, and how to adapt to the disease. Researchers measured patients' medication adherence, disease coping, and self-efficacy before and after the education. The goal is to see if this simple educational tool can improve patients' ability to manage their treatment and daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
training booklet
What this could lead to
If successful, this educational approach could help kidney patients better manage their medication and adapt to their disease, improving their quality of life.
What could go wrong
This is a small, early-stage study with only 78 participants, so results may not apply to all patients. The intervention is educational, not a drug, so it cannot directly treat the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

78 people

The number who actually took part.

Started

Nov 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients receiving immunosuppressive therapy for the first time at the nephrology and transplantation clinics of Trakya University Hospital, * Aged 18 years or older, * Literate, * Without communication or mental disorders, * Without motor skill impairments, * Patients who consent to participate in the study Exclusion Criteria: * Patients who are not willing to participate in the study, * Patients who are illiterate, * Patients with communication or mental problems, * Patients with motor skill problems, * Patients who wish to withdraw from the study at any stage, * Patients who do not attend follow-up appointments, * Patients undergoing dialysis treatment and not receiving immunosuppressive therapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome Patient Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease Immunosuppressive therapy

Contacts and locations

Locations

  • Trakya University Hospital

    Edirne, Edirne, 22100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.